内镜下乳头大球囊扩张可减少复发性胆总管结石患者的再次复发:一项随机对照试验
该随机对照试验将180例复发性胆总管结石患者按1:1分为内镜下乳头大球囊扩张(EPLBD)组和对照组,各90例。EPLBD组2年内结石复发率显著低于对照组(21.1% vs 36.7%,相对危险度0.58,95%CI 0.36-0.93,P=0.021),中位随访约56个月时复发率亦显著降低(34.4% vs 51.1%,风险比0.57,95%CI 0.36-0.89,P=0.012)。
要点
- EPLBD组一次ERCP完全清除率显著高于对照组(95.6% vs 85.6%,P=0.017)。
- EPLBD组2年内结石复发率显著低于对照组(21.1% vs 36.7%,P=0.021)。
- EPLBD组多次复发(≥2次)比例显著低于对照组(4.4% vs 18.9%,P=0.020)。
核心结论
- EPLBD可有效减少复发性胆总管结石患者经ERCP后的结石复发。
- 长期随访中近半数复发性胆总管结石患者在接受传统ERCP后仍出现结石复发。
研究设计与样本
- 随机对照试验,2014年至2021年纳入180例复发性胆总管结石患者,按1:1随机分为EPLBD组和对照组,每组90例。
- 主要结局为ERCP后2年内胆总管结石复发率,分析遵循意向性治疗原则。
主要发现
- 一次ERCP完全清除率EPLBD组为95.6%,对照组为85.6%,差异显著(P=0.017)。
- 2年内结石复发率EPLBD组为21.1%(19/90),对照组为36.7%(33/90),相对危险度0.58(95%CI 0.36-0.93,P=0.021)。
- 中位随访约56个月时,结石复发率EPLBD组为34.4%(31/90),对照组为51.1%(46/90),风险比0.57(95%CI 0.36-0.89,P=0.012)。
- 多次复发(≥2次)比例EPLBD组为4.4%,对照组为18.9%,差异显著(P=0.020)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Up to 60% of patients with common bile duct stone (CBDS) recurrence suffer from further recurrence after endoscopic retrograde cholangiopancreatography (ERCP). There are no effective methods to prevent recurrence in most patients. In this study, we aimed to assess the short-term and long-term efficacies of endoscopic papillary large balloon dilation (EPLBD) for the management of recurrent CBDS in a randomized controlled trial. METHODS: Consecutive patients with recurrent CBDS were eligible and randomly assigned in a 1:1 ratio to the EPLBD group or the control group. The primary outcome was the CBDS recurrence rate within 2 years after ERCP. The analysis followed the intention-to-treat principle. RESULTS: From 2014 to 2021, 180 patients with recurrent CBDS were included, with 90 in each group. All patients underwent complete CBDS clearance by 1 or several sessions of ERCP. The rate of complete clearance in 1 session was significantly higher with EPLBD treatment (95.6% vs 85.6%, P = 0.017). During the follow-up, the CBDS recurrence rate within 2 years was significantly lower in the EPLBD group than in the control group (21.1% [19/90] vs 36.7% [33/90], relative risk 0.58, 95% confidence interval 0.36-0.93, P = 0.021). At a median follow-up of approximately 56 months, CBDS recurrence was found in 34.4% of the patients (31/90) in the EPLBD group and 51.1% (46/90) in the control group (hazard ratio 0.57, 95% confidence interval 0.36-0.89, P = 0.012). Multiple recurrences (≥2) were also decreased in the EPLBD group (4.4% vs 18.9%, P = 0.020). DISCUSSION: During the long-term follow-up, nearly half of the patients with recurrent CBDS experienced stone recurrence after traditional ERCP. Our study was the first to show that EPLBD effectively reduced the recurrence of CBDS.
引用
- Wang X, Wang X, Sun H, et al. Endoscopic Papillary Large Balloon Dilation Reduces Further Recurrence in Patients With Recurrent Common Bile Duct Stones: A Randomized Controlled Trial. Am J Gastroenterol. 2022. PMID: 35191430. doi:10.14309/ajg.0000000000001690
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。